Merck Serono International S.A.

Q2 2008

Publication of Merck Group business results for 2nd quarter of 2008:

Total revenues for the Merck Serono division rose 8.3% (organic growth of 13%)

In the News

July 23, 2008Merck Serono Receives European Approval for Broader Usage of Erbitux in Metastatic Colorectal Cancer Including First-Line Treatment

Fast Facts

Total revenues in euros generated by Merck Serono products in 2007

Welcome to Merck Serono

Welcome to the Merck Serono International S.A. website

Merck Serono is the division for innovative small molecules and biopharmaceuticals of Merck KGaA.

Merck Serono’s global headquarters are located in Geneva, Switzerland. In the United States and Canada, the division operates as EMD Serono.

Copyright© 2007-2008 Merck Serono International S.A.
Merck Serono is a division of Merck KGaA in Darmstadt, Germany.
Residents of the United States should consult the EMD Serono, Inc.
website for information on products and services approved in the US.

Last updated: 23/07/2008Legal Statement